DekaBank Deutsche Girozentrale increased its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,449,621 shares of the company's stock after buying an additional 32,494 shares during the period. Procter & Gamble accounts for approximately 1.3% of DekaBank Deutsche Girozentrale's investment portfolio, making the stock its 9th biggest position. DekaBank Deutsche Girozentrale owned approximately 0.19% of Procter & Gamble worth $711,324,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the company. Bogart Wealth LLC increased its holdings in Procter & Gamble by 2.7% during the second quarter. Bogart Wealth LLC now owns 68,413 shares of the company's stock worth $10,900,000 after buying an additional 1,818 shares during the last quarter. Drive Wealth Management LLC increased its holdings in Procter & Gamble by 3.1% during the second quarter. Drive Wealth Management LLC now owns 8,037 shares of the company's stock worth $1,280,000 after buying an additional 245 shares during the last quarter. Schnieders Capital Management LLC increased its holdings in Procter & Gamble by 2.8% during the second quarter. Schnieders Capital Management LLC now owns 30,182 shares of the company's stock worth $4,809,000 after buying an additional 809 shares during the last quarter. Crewe Advisors LLC increased its holdings in Procter & Gamble by 3.9% during the second quarter. Crewe Advisors LLC now owns 8,756 shares of the company's stock worth $1,395,000 after buying an additional 327 shares during the last quarter. Finally, Lyell Wealth Management LP increased its holdings in Procter & Gamble by 50.5% during the second quarter. Lyell Wealth Management LP now owns 5,811 shares of the company's stock worth $926,000 after buying an additional 1,950 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Procter & Gamble
In related news, CFO Andre Schulten sold 4,252 shares of the company's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares of the company's stock, valued at $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Balaji Purushothaman sold 490 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider directly owned 12,616 shares of the company's stock, valued at $1,920,533.68. This represents a 3.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 over the last three months. 0.20% of the stock is owned by insiders.
Procter & Gamble Trading Up 1.3%
Shares of Procter & Gamble stock opened at $151.53 on Monday. The firm has a 50-day moving average of $154.92 and a 200-day moving average of $158.67. The stock has a market cap of $354.66 billion, a PE ratio of 23.28, a PEG ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter in the previous year, the business posted $1.40 earnings per share. Procter & Gamble's quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble's dividend payout ratio is currently 64.98%.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of research analyst reports. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Berenberg Bank lifted their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research report on Wednesday, September 17th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Barclays reduced their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research report on Friday, October 10th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus price target of $172.21.
View Our Latest Stock Report on PG
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report